Optimizing Ventilation for Patients with Acute Respiratory Distress Syndrome
Official title: Careful Ventilation in Acute Respiratory Distress Syndrome
Run by Unity Health Toronto · NCT03963622 · Data updated 2026-11-12
This study tests a new way of using ventilators to see if it can help patients with acute respiratory distress syndrome, including those with COVID-19, live longer and breathe better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 740 (estimated) |
| Sponsor | Unity Health Toronto Academic / other |
| Locations | 33 sites (New York, New York and 32 other locations) |
| Status | Recruiting |
| Started | November 23, 2020 |
| Main results expected | June 2027 |
| Study ends | September 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT03963622 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with moderate to severe ARDS within 48 hours of meeting Berlin ARDS criteria.
✕Probably not a fit
Patients who have been on continuous mechanical ventilation for more than 7 days or have severe comorbid conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized controlled trial evaluates the effectiveness of a ventilator management strategy based on respiratory mechanics to reduce mortality in patients with acute respiratory distress syndrome (ARDS). The study includes both COVID-19 and non-COVID-19 patients, utilizing a basket trial design to implement a standardized mechanical ventilation protocol across different populations. By assessing the recruitability and effort of patients, the trial aims to improve ventilation outcomes and minimize ventilator-induced lung injury. The trial's adaptive design allows for modifications based on interim results to enhance patient care.
Why it matters
Potential benefit: If successful, this approach could significantly lower mortality rates in ARDS patients by improving ventilation strategies.
How similar studies have gone: Other studies have shown promise in optimizing mechanical ventilation strategies for ARDS, suggesting potential for success in this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 y 2. Moderate or severe ARDS (PaO2/FiO2 ≤ 200 mmHg) within 48 h of meeting Berlin ARDS criteria (Patients who were eligible at the time of screening and whose PaO2/FiO2 became \> 200 mm Hg under prone positioning when starting the protocol remained eligible) Exclusion Criteria: 1. Received continuous mechanical ventilation \> 7 days 2. Known or clinically suspected elevated intracranial pressure (\>18mmHg) necessitating strict control of PaCO2 3. Known pregnancy 4. Broncho-pleural fistula 5. Severe liver disease (Child-Pugh Score ≥ 10) 6. BMI \>40kg/m2 7. Anticipating withdrawal of life support and/or shift to palliation as the goal of care 8. Patient is receiving ECMO at time of randomization
Where it's running
-
New York University Grossman School of Medicine
New York, New York, United States Recruiting -
Centro de Educación Médica e Investigaciones Clínicas Dr Norberto Quirno (CEMIC)
Buenos Aires, Argentina Recruiting -
Complejo Médico Policía Federal Argentina Churruca Visca
Buenos Aires, Argentina Recruiting -
Hospital Británico de Buenos Aires
Buenos Aires, Argentina Recruiting -
Sanatorio Anchorena Recoleta
Buenos Aires, Argentina Recruiting -
Sanatorio Mater Dei
Buenos Aires, Argentina Recruiting
Show 27 more locations
-
Sanatorio Anchorena San Martín
San Martin, Argentina Recruiting -
St. Michael's Hospital
Toronto, Canada Recruiting -
Toronto General Hospital
Toronto, Canada Recruiting -
Toronto Western Hospital
Toronto, Canada Recruiting -
Pontificia Universidad Católica de Chile
Santiago, Chile Recruiting -
CHU Amiens-Picardie
Amiens, France Recruiting -
Centre hospitalier universitaire d'Angers
Angers, France Recruiting -
CH Victor Dupouy
Argenteuil, France Recruiting -
CH de Beauvais
Beauvais, France Recruiting -
CHU Bordeaux - Haut Leveque
Bordeaux, France Recruiting -
Hopital de la Cavale Blanche - CHRU Brest
Brest, France Recruiting -
CH de Cholet
Cholet, France Recruiting -
Hopital Intercommunal de Creteil
Créteil, France Recruiting -
CHU Grenoble-Alpes
Grenoble, France Recruiting -
Hopital Roger Salengro - CHU Lille
Lille, France Recruiting -
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Mulhouse, France Recruiting -
Hopital de l'Archet 1 - CHU de Nice
Nice, France Recruiting -
Hopital Europeen Georges-Pompidou
Paris, France Recruiting -
CHU de Poitiers - La Miletrie
Poitiers, France Recruiting -
CH Bretagne Atlantique Vannes-Auray
Vannes, France Recruiting -
HIA Robert Picque
Villenave-d'Ornon, France Recruiting -
Arcispedale Sant'Anna
Ferrara, Italy Recruiting -
University of Foggia
Foggia, Italy Recruiting -
Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy Recruiting -
Olvg
Amsterdam, North Holland, Netherlands Recruiting -
L'Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting -
Vall d'Hebron University Hospital
Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Laurent Brochard, MD — Unity Health Toronto
- Study coordinator: Laurent Brochard, MD
- Email: laurent.brochard@unityhealth.to
- Phone: 416-864-6060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicenter group study of sepsis and ARDS in China
This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
TwitchView-guided Atracurium Dose Adjustment in ICU Patients
This trial tests whether using a TwitchView EMG monitor to guide atracurium dosing in ICU patients reduces the total amount of the drug given without compromising care.
-
Fibrinogen-to-Albumin Ratio as a Predictor of ARDS in Traumatic Brain Injury
This study tests whether the fibrinogen-to-albumin ratio can predict who among adults with traumatic brain injury will develop acute respiratory distress syndrome (ARDS).
-
Gastric versus postpyloric feeding for adults with ARDS on prone ventilation
This trial will test whether feeding through a stomach tube (nasogastric) or a tube placed past the stomach (nasojejunal) works better for adults with moderate to severe ARDS who are on a ventilator and positioned face-down.
-
Using higher PEEP with mask noninvasive ventilation for people with pneumonia or ARDS
This trial will test whether giving higher PEEP through a mask during noninvasive ventilation helps adults with pneumonia or ARDS avoid intubation and improve oxygenation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.